ARTICLE | Company News
Silence Therapeutics management update
January 7, 2013 8:00 AM UTC
Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Transitioned: Michael Khan, a director, to CMO from chief medical adviser ...